[
  {
    "ts": "2025-11-29T08:12:31+00:00",
    "headline": "Assessing AbbVie’s (ABBV) Valuation: Is There More Upside After Recent Performance?",
    "summary": "AbbVie (ABBV) shares are holding steady as investors assess the company’s ongoing performance following recent earnings. With key drugs still leading the portfolio, many are watching how AbbVie manages steady growth in a competitive sector. See our latest analysis for AbbVie. AbbVie’s share price has steadily climbed this year, with a year-to-date return of nearly 27%. The company’s recent updates have not slowed its momentum, as investor confidence continues to build. This is reflected in an...",
    "url": "https://finance.yahoo.com/news/assessing-abbvie-abbv-valuation-more-081231617.html",
    "source": "Simply Wall St.",
    "provider": "yfinance",
    "raw": {
      "id": "2ce89828-eb5f-38e3-abc4-0514575cec3e",
      "content": {
        "id": "2ce89828-eb5f-38e3-abc4-0514575cec3e",
        "contentType": "STORY",
        "title": "Assessing AbbVie’s (ABBV) Valuation: Is There More Upside After Recent Performance?",
        "description": "",
        "summary": "AbbVie (ABBV) shares are holding steady as investors assess the company’s ongoing performance following recent earnings. With key drugs still leading the portfolio, many are watching how AbbVie manages steady growth in a competitive sector. See our latest analysis for AbbVie. AbbVie’s share price has steadily climbed this year, with a year-to-date return of nearly 27%. The company’s recent updates have not slowed its momentum, as investor confidence continues to build. This is reflected in an...",
        "pubDate": "2025-11-29T08:12:31Z",
        "displayTime": "2025-11-29T08:12:31Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/simply_wall_st__316/4451284b0632c6e74466a63400764edd",
          "originalWidth": 1194,
          "originalHeight": 432,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/cbaG7tZ9A8mqrilci3AeIQ--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/4451284b0632c6e74466a63400764edd.cf.webp",
              "width": 1194,
              "height": 432,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/1OA9tdPdimVe1Dv1fa4MAQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/simply_wall_st__316/4451284b0632c6e74466a63400764edd.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Simply Wall St.",
          "url": "https://simplywall.st/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/assessing-abbvie-abbv-valuation-more-081231617.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/assessing-abbvie-abbv-valuation-more-081231617.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "ABBV"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]